Manulife (Manufacturers Life Insurance)
APLS

Manulife (Manufacturers Life Insurance)’s Apellis Pharmaceuticals APLS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,765
Closed -$996K – 2881
2026
Q1 		$996K Buy
24,765
+1,913
+8% +$41.2K ﹤0.01% 1831
2025
Q4 		$574K Buy
22,852
+143
+0.6% +$3.35K ﹤0.01% 2115
2025
Q3 		$514K Buy
22,709
+736
+3% +$17.2K ﹤0.01% 2196
2025
Q2 		$380K Sell
21,973
-2,964
-12% -$54.9K ﹤0.01% 2281
2025
Q1 		$545K Sell
24,937
-27,960
-53% -$772K ﹤0.01% 2102
2024
Q4 		$1.69M Sell
52,897
-8,324
-14% -$250K ﹤0.01% 1643
2024
Q3 		$1.77M Sell
61,221
-11,914
-16% -$441K ﹤0.01% 1614
2024
Q2 		$2.81M Sell
73,135
-50,195
-41% -$2.27M ﹤0.01% 1389
2024
Q1 		$7.25M Buy
123,330
+17,328
+16% +$1.1M 0.01% 1015
2023
Q4 		$6.35M Buy
106,002
+51,737
+95% +$2.62M ﹤0.01% 1057
2023
Q3 		$2.06M Sell
54,265
-115,408
-68% -$5.07M ﹤0.01% 1426
2023
Q2 		$15.5M Buy
169,673
+33,077
+24% +$2.85M 0.01% 657
2023
Q1 		$9.01M Buy
136,596
+53,766
+65% +$3.1M 0.01% 837
2022
Q4 		$4.27M Sell
82,830
-10,254
-11% -$544K ﹤0.01% 1138
2022
Q3 		$6.19M Sell
93,084
-3,792
-4% -$224K ﹤0.01% 951
2022
Q2 		$4.38M Sell
96,876
-3,423
-3% -$156K ﹤0.01% 1154
2022
Q1 		$5M Buy
100,299
+64,350
+179% +$2.84M ﹤0.01% 1184
2021
Q4 		$1.72K Buy
35,949
+1,925
+6% +$75.8K ﹤0.01% 1561
2021
Q3 		$1.12M Sell
34,024
-2,733
-7% -$154K ﹤0.01% 1766
2021
Q2 		$2.32M Buy
36,757
+2,541
+7% +$131K ﹤0.01% 1544
2021
Q1 		$1.47M Sell
34,216
-2,062
-6% -$97.6K ﹤0.01% 1682
2020
Q4 		$2.08M Buy
36,278
+940
+3% +$39.8K ﹤0.01% 1523
2020
Q3 		$1.07M Sell
35,338
-635
-2% -$19K ﹤0.01% 1629
2020
Q2 		$1.11M Buy
35,973
+231
+0.6% +$7.42K ﹤0.01% 1570
2020
Q1 		$958K Buy
35,742
+6,191
+21% +$220K ﹤0.01% 1534
2019
Q4 		$905K Sell
29,551
-1,126
-4% -$31.2K ﹤0.01% 1726
2019
Q3 		$749K Buy
30,677
+248
+0.8% +$6.83K ﹤0.01% 1790
2019
Q2 		$771K Buy
30,429
+5,918
+24% +$120K ﹤0.01% 1784
2019
Q1 		$478K Buy
24,511
+1,797
+8% +$28.3K ﹤0.01% 2112
2018
Q4 		$299K Sell
22,714
-1,822
-7% -$28K ﹤0.01% 2166
2018
Q3 		$436K Sell
24,536
-2,978
-11% -$55K ﹤0.01% 2379
2018
Q2 		$606K Buy
27,514
+17,912
+187% +$412K ﹤0.01% 2228
2018
Q1 		$213K Buy
9,602
+1,051
+12% +$20.7K ﹤0.01% 2974
2017
Q4 		$186K Buy
+8,551
New +$126K ﹤0.01% 3057

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s APLS Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 24,765 shares — an estimated $996K sold.

Manulife (Manufacturers Life Insurance) first reported a position in APLS in Q4 2017 and held it in 34 quarters. The position peaked at $15.5M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,765 Apellis Pharmaceuticals shares in Q2 2026, an estimated $996K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 34 quarters.
  • Manulife (Manufacturers Life Insurance)'s Apellis Pharmaceuticals position peaked at $15.5M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.